ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686393 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686393; 2) Community: the network communities that were significantly associated with the response to NSC 686393; 3) Molecule: the relationships between components within communities and NSC 686393; 4) MDR: the compounds that were significantly associated with the NSC 686393.

NSC Compound Enrichment Correlation
NSC 710326 Null 0.0237269271456697 0.17049451
NSC 717953 Null 0.0237269271456697 0.029003532
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0237269271456697 0.26140653
NSC 720134 Null 0.0237269271456697 -0.10397863
NSC 753598 Null 0.0237269271456697 0.028092273
NSC 708048 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- 0.0291420747327558 -0.014250188
NSC 711066 Null 0.0291420747327558 -0.13036651
NSC 740963 Null 0.0291420747327558 0.15496494
NSC 744989 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0291420747327558 0.21196842
NSC 745321 Null 0.0291420747327558 0.036258715
Total:32  Current:16    [First] [Prev] [Next] [Last]